Not Your Average Knockout: Introducing Cell Editing with XDel CRISPR Technology
Disease Models, iPS Cells, Immortalized Cell Lines | January 28, 2025 | By Amalia Soenens
With years of experience and hundreds of thousands of successful edits, this journey has given us invaluable insights into one of the biggest challenges scientists face in the CRISPR knockout space: the extensive optimization and rework often required to confidently achieve a gene knockout.
Recognizing this challenge, we asked ourselves: How can we use our expertise to design a more efficient and reliable method to knock out genes? By focusing on this mission, EditCo has developed innovative solutions that streamline the knockout process, empowering researchers to achieve their goals with greater confidence.
EditCo’s Solution for Better Knockouts: XDel Technology
To address the inefficiencies of traditional CRISPR knockout strategies, we developed a solution: a set of predesigned guide RNAs (gRNAs) targeting a single exon of a gene that work cooperatively to increase editing efficiency by creating targeted fragment deletions. Unlike the standard approach, which relies on a single gRNA to introduce random indels at one site—or multiple gRNAs that randomly target different regions—our method is specifically designed to create coordinated deletions that reliably disrupt the gene. This approach improves the likelihood of generating a complete functional knockout, reducing the unpredictability and inefficiency associated with traditional strategies.
By analyzing 7 endogenous loci in 4 cell lines, XDel knockout technology delivers significantly higher and more consistent on-target editing compared to single-guide, ensuring superior editing performance in immortalized cells and iPSCs.

XDel Knockout Cells Enable High and Sustained Protein Depletion - Guaranteed Editing Efficiency and Delivered in 4 Weeks (Pools) or 10 Weeks (Clones)

Click to view the full-size image
Figure 3. A) Four membrane proteins were knocked out in K562 cells using XDel technology, following EditCo Bio’s proprietary workflow. Protein levels were assessed via flow cytometry at four time points: days 3, 7, 14, and 21 post-transfection, and compared to negative controls (non-edited cells or cells electroporated with Cas9 only). Membrane protein depletion remained stable over time, and cell viability was consistently high (>90%) across all samples. B) Representative flow cytometry plots showing protein levels for CD46 and CD59 in XDel knockout pools at 21 days post-editing.
Derisking Unintentional Edits: XDel Knockout Cells Actually Have Fewer Off-target Edits Than Single-guide
A common concern with multi-guide approaches is the potential for off-target edits. To address this, we rigorously tested XDel Knockout Cells to ensure it produces high-quality knockouts with minimal off-target effects. Our data shows that XDel guide designs not only maximize on-target gene editing efficiency but also significantly minimize off-target edits compared to single-guide strategies.


XDel Knockout Cells show persistent protein depletion, enabling their direct and reliable use in functional assays
Achieving a functional knockout is essential to be able to use edited cells for downstream assays. Edited cell pools generated using our XDel gRNA design demonstrate persistent protein depletion, a key indicator of effective gene disruption. This ensures that the cell pools can be directly used in functional assays without requiring additional validation or rework and provide reliable long-term functional data.

Off-target editing is minimized, in part, due to lower gRNA concentration made possible through synergistic multi-guide cooperation
The cooperative effect of XDel guide design allows for lower gRNA concentration while maintaining high editing efficiency and minimizing unwanted off-target editing.

Doing a CRISPR screen and want to skip ahead?
Our high-efficiency predesigned guides, combined with optimized CRISPR workflows and automation, create the ideal combination for producing high-quality, rapid and reliable knockout edits. This seamless integration ensures that researchers can achieve consistent results at scale, reducing variability and accelerating their research.
| Knockout Cells | Knockout Cell Libraries | |
|---|---|---|
| Formats | Pools & Clones | Pools |
| Cell Types | iPS & Immortalized | iPS & Immortalized |
| Cell Source | EditCo- & Customer-Supplied | EditCo- & Customer-Supplied |
| Output | 2 vials of cell pools or 2 independent clones (500,000 - 1,000,000 cells/vial) | 2 vials of each pool (20,000 cells/vial) |
| Minimum order | N/A | 20 pools |
| QC | NGS, including comprehensive QC report | Sanger Sequencing, including comprehensive QC report |
| Add-ons | Additional clones and pools, intermediate pools | Additional pools |
Learn More and Take the Next Step
Whether conducting gene function studies, modeling diseases, or drug discovery, EditCo is your trusted partner in CRISPR knockout research. Our innovative approach delivers:
- High Efficiency: Achieve higher on-target editing rates and consistent knockout performance
- Reliable Results: Persistent protein depletion, validated through function assays
- Enhanced Reproducibility: Minimize variability for dependable outcomes across experiments
Ready to accelerate your research with robust gene knockouts?
- Learn more about XDel Knockout Design in Immortalized Cells and iPS Cells
- Download the XDel Case Study:
Rapid, Reliable Knockouts for Cancer Biology with XDel Technology: Unveiling SURF2’s Role in Nucleolar Stress and Its Potential as a Therapeutic Target - Explore more data in XDel Application Note:
Optimized CRISPR/Cas9 Gene Knockout: XDel technology maximizes on-target editing and minimizes off-target effects - Contact Us


